Clinical Trial Supplies Market to be dominated by Oncology Segment through 2028
Rising research & development
of innovative drugs and therapies is expected to drive the growth of Global Clinical
Trial Supplies Market during the forecast period.
According to TechSci Research report, “Clinical Trial Supplies Market - Global Industry Size, Share, Trends,
Competition, Opportunity, and Forecast, 2018-2028,” the rising demand from pharmaceutical
companies for evaluating the safety and efficacy of new treatments and
therapies has led to the development of biologics and biosimilars requiring
clinical trials to establish similarity in terms of safety, efficacy, and
quality compared to the reference biologic. These trials necessitate adequate
supplies of both the biosimilar and the reference product for comparative
evaluations. The rapid progress in biotechnology has opened up new avenues for
drug discovery and development. Biotech companies are leveraging technologies
such as gene editing, gene therapy, RNA interference, and cell-based therapies
to develop innovative treatments. These advanced therapeutic modalities often
require extensive clinical testing to assess their safety and efficacy, leading
to a higher demand for clinical trials.
Precision medicine, which designs
treatments for individual patients based on their genetic makeup and other
personalized factors, has gained prominence. Pharmaceutical and biotech
companies are investing in R&D efforts to develop targeted therapies for
specific patient populations. This personalized approach often necessitates
conducting clinical trials with well-defined patient cohorts, resulting in an
increased demand for clinical trial participation.
The increase in clinical studies
being undertaken on a global scale is expanding the clinical trial supplies
market growth. More researchers, pharmaceutical companies, and contract
research organizations (CROs) are participating in clinical trials across a
wide range of therapeutic areas as a result of improvements in medical
understanding and the demand for evidence-based therapy. The need for clinical
trial supplies, such as investigational medications, medical devices,
laboratory materials, and diagnostic instruments, rises due to the increase in
trial activity.
Clinical trials are highly in
demand for the development of therapeutic and efficient drug developments.
Clinical trials in gastroenterology focus on gastrointestinal disorders such as
Crohn's disease, ulcerative colitis, irritable bowel syndrome (IBS), and
gastroesophageal reflux disease (GERD). These trials evaluate new medications,
biologics, probiotics, dietary interventions, and surgical procedures to
enhance disease control, manage symptoms, and improve the quality of life for
patients. For instance, clinical trials in endocrinology address disorders of
the endocrine system, including diabetes, thyroid diseases, osteoporosis, and
hormone-related conditions. Trials may involve testing new insulin
formulations, antidiabetic medications, hormonal therapies, and evaluating
novel approaches for disease management, prevention, and early detection.
Clinical trials in oncology focus
on the development of new cancer treatments, including chemotherapy drugs,
targeted therapies, immunotherapies, and radiotherapy techniques. Trials may
involve assessing the effectiveness of novel drugs, exploring combination
therapies, evaluating the role of immunotherapy in different cancer types, and
investigating personalized medicine approaches based on genetic or biomarker
profiles.
Moreover, the COVID-19 pandemic
has also significantly impacted the demand for clinical trial supplies. The
global response to the pandemic has accelerated the development of vaccines,
therapeutics, and diagnostics, leading to an unprecedented number of clinical
trials related to COVID-19. The urgency to find effective treatments and
preventive measures has created an immense demand for trial supplies, including
vaccines, monoclonal antibodies, and diagnostic kits.
The globalization of clinical
trials has created a need for supplies to be distributed across different
geographical locations. This includes sourcing and delivering trial materials
to various sites, ensuring consistent quality and adherence to regulatory requirements.
Additionally, technological
advancements have revolutionized the field of clinical trials, driving the
demand for specialized supplies. For example, the rise of precision medicine
and genomics has led to the development of companion diagnostics and targeted
therapies. Furthermore, digital health technologies, electronic data capture,
and wearables are increasingly incorporated into clinical trials, requiring
compatible supplies to support data collection and analysis.
Browse over XX market data Figures spread through 165 Pages and an
in-depth TOC on "Global Clinical Trial Supplies Market”
Global Clinical Trial Supplies
Market can be segmented based on services, type, therapeutic areas, end user, region,
and company.
Based on services, the market is
segmented into manufacturing, packaging labeling & binding, logistics &
distribution, storage & retention, comparator sourcing, and others.
Logistics & distribution are expected to hold the highest share in the
forecast period on account of the growing adoption of logistics &
distribution in an extended range. Additionally, the rising number of clinical
trials and increased globalization of clinical trials are anticipated to propel
the growth of this segment.
Based on type, the market can be
segmented into small molecule drugs, biologics drugs, and medical devices. The
biologics drugs segment is expected to show impressive growth in the forecast
period due to growing research & development activities such as the
development of biosimilar products and other nanoparticle-based drug delivery
systems. Biosimilars and biologics are produced using highly intricate
manufacturing techniques using living cells.
Based on therapeutic areas, the
market is segmented into oncology, CNS and mental disorders, cardiovascular
diseases, digestive disorders, infectious diseases, metabolic disorders, blood
disorders, immunology, and other therapeutic disorders. The oncology segment is
expected to hold the highest share in the forecast period due to the increasing
prevalence of cancer across several regions. Also, the rising research &
development along with the growing cancer drug development correspondingly
increases the demand for clinical trial supplies.
Based on region, North America
dominated the market in 2022 on account of the largest number of clinical
trials across the region. Also, technological advancements & government
funding are major factors that contributed to the growth of clinical trial
supplies market in North America. Asia Pacific is expected to have the highest
share in the forecast period. This can be attributed to the existence of a low
cost of conducting clinical trials and the easy patient recruitment rate for clinical
trials compared to other developed nations.
The leading companies operating in
the Global Clinical Trial Supplies Market are:
- Thermo Fisher
Scientific Inc.
- Catalent Inc
- Almac Group
- PRA Health
Sciences
- Piramal Pharma
Solutions
- Clinigen Group
Plc
- Eurofins
Scientific SE
- Parexel
International Corporation
Download Free Sample Report
Customers can also
request for 10% free customization on this report.
Asia Pacific is expected to dominate
the Global Clinical Trial Supplies Market during the forecast period due to the
rising prevalence of various chronic diseases and increasing research &
development of new therapeutic drugs, leading to increased clinical trials.
Additionally, a large patient pool, comparatively lower operating clinical
trial costs than other developed countries and increasing governmental support
and investments for clinical trials are major factors expected to influence the
growth of the global Clinical Trial Supplies Market in the coming years,"
said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based global management consulting firm.
“Clinical Trial Supplies Market - Global Industry Size,
Share, Trends, Competition, Opportunity, and Forecast, 2018-2028
Segmented By Services (Manufacturing, Packaging Labeling
& Blinding, Logistics & Distribution, Storage & Retention,
Comparator Sourcing, Other), By Type (Small Molecule Drugs, Biologics Drugs,
Medical Devices), By Therapeutic Areas ( Oncology, CNS and Mental Disorders
Cardiovascular Diseases, Digestive Disorders, Infectious Diseases, Metabolic Disorders,
Blood Disorders, Immunology and Other Therapeutic Disorder), By End User
(Pharmaceutical, Biotechnology Companies, Contract Research Organizations
(CROs)), By Region and Competition,” has evaluated the future growth potential of Global Clinical Trial
Supplies Market and provides statistics & information on market size,
structure, and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Clinical Trial
Supplies Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email:
[email protected]
Website:
https://www.techsciresearch.com